Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on Dec 15, 2024 3:47pm
82 Views
Post# 36363288

RE:RE:RE:RE:RE:FORMAL TAKEOVER BID.

RE:RE:RE:RE:RE:FORMAL TAKEOVER BID.
alleyesonme wrote: If true, the shares wouldn't be acquired on the open market, it would be a private placement adding to the share count. What do you make of the acceleration of RSU's by 13 days? I see this as concern they could be paused during the formal aqusition process..potentially being scrapped altogether once the new owner takes over...parties often have dialogue months even years before terms of a friendly takeover are supported...this explains much about behaviour over the last year..additionally takeovers happen prior to big news like the launch of a new drug and or epidiolex generic, the impending rescheduling of cannabis..the time is now...IMO this latest development..RSU acceleration only means one thing..add this to the departure of keith and the writings on the wall..the good news is current share price is irrelevant...compared to metrics evaluating other cannabis company's MPL is seriously undervalued...applying metrics for pharmaceutical corps, massively undervalued...typically these "metrics are applied to come up with a current valuation, then a premium is applied...so anyone's guess but I would imagine leadership will only endorse a very solid, strong offer. Its going to be a very interesting month IMO..


The lunacy has reached a fever pitch.  There is no reason to read anything into 'accelerated' RSUs anymore than the other blather about NDA/ANDA/etc.

I've told you before, ANDA is Epi, NDA isn't an NDA, it is an investigational NDA and the whole idea of selling the company on the basis of cloak and daggar secrecy makes no sense.

You want to believe something big is imminent.  That's fine.  There is nothing of substance that points to that happening.

If anything, Pidduck likely has picked his next failed business victim to scoop up.
<< Previous
Bullboard Posts
Next >>